Literature DB >> 28067033

2016 Updated American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards, Including Standards for Pediatric Oncology

Michael Neuss, Terry Gilmore, Kristin Belderson, Amy Billett, Tara Conti-Kalchik, Brittany Harvet, Carolyn Hendricks, Kristine LeFebvre, Pamela Mangu, Kristen McNiff, MiKaela Olsen, Lisa Schulmeister, Anne Von Gehr, Martha Polovich.   

Abstract

Purpose: To update the American Society of Clinical Oncology (ASCO)/Oncology Nursing Society (ONS) Chemotherapy Administration Safety Standards and to highlight standards for pediatric oncology.
Methods: The ASCO/ONS Chemotherapy Administration Safety Standards were first published in 2009 and updated in 2011 to include inpatient settings. A subsequent 2013 revision expanded the standards to include the safe administration and management of oral chemotherapy. A joint ASCO/ONS workshop with stakeholder participation, including that of the Association of Pediatric Hematology Oncology Nurses and American Society of Pediatric Hematology/Oncology, was held on May 12, 2015, to review the 2013 standards. An extensive literature search was subsequently conducted, and public comments on the revised draft standards were solicited.
Results: The updated 2016 standards presented here include clarification and expansion of existing standards to include pediatric oncology and to introduce new standards: most notably, two-person verification of chemotherapy preparation processes, administration of vinca alkaloids via minibags in facilities in which intrathecal medications are administered, and labeling of medications dispensed from the health care setting to be taken by the patient at home. The standards were reordered and renumbered to align with the sequential processes of chemotherapy prescription, preparation, and administration. Several standards were separated into their respective components for clarity and to facilitate measurement of adherence to a standard.
Conclusion: As oncology practice has changed, so have chemotherapy administration safety standards. Advances in technology, cancer treatment, and education and training have prompted the need for periodic review and revision of the standards. Additional information is available at http://www.asco.org/chemo-standards.

Entities:  

Year:  2017        PMID: 28067033     DOI: 10.1188/17.ONF.31-43

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  14 in total

1.  Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.

Authors:  Kristin S Kicenuik; Nicole C Northrup; Dawn M Clarke; Lisa J Bazzle
Journal:  Can Vet J       Date:  2018-10       Impact factor: 1.008

2.  Patient and provider perspectives on delivery of oral cancer therapies.

Authors:  Caitlin C Murphy; Simon J Craddock Lee; David E Gerber; John V Cox; Hannah M Fullington; Robin T Higashi
Journal:  Patient Educ Couns       Date:  2019-06-20

Review 3.  Domains of Structured Oral Anticancer Medication Programs: A Scoping Review.

Authors:  Kapeena Sivakumaran; Pamela K Ginex; Haya Waseem; Sarah M Belcher; Sarah Lagler-Clark; Kristine B LeFebvre; Nicole Palmer; Tejanth Pasumarthi; Rebecca L Morgan
Journal:  Oncol Nurs Forum       Date:  2022-06-17       Impact factor: 1.803

Review 4.  Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review.

Authors:  Marco Di Nitto; Fabio Sollazzo; Valentina Biagioli; Gianluca Pucciarelli; Francesco Torino; Rosaria Alvaro; Ercole Vellone
Journal:  Support Care Cancer       Date:  2022-05-31       Impact factor: 3.359

5.  Allergic Reactions Captured by Voluntary Reporting.

Authors:  Kimberly G Blumenthal; Anna R Wolfson; Yu Li; Claire M Seguin; Neelam A Phadke; Aleena Banerji; Elizabeth Mort
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.844

Review 6.  A Concept Analysis of Oral Anticancer Agent Self-management.

Authors:  Madilyn Mason; Marcelline R Harris; Joseph A Greer; Yun Jiang
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

7.  Continuing cancer care in a religious facility: A feasible alternative in the COVID-19 Pandemic Era?

Authors:  Jose Enrique Montoya; Lorraine Marie Item; Shaira Ann Ganggay; Katrin Jovellanos; Jonah Marie Punzalan; Glory Baltazar
Journal:  J Cancer Policy       Date:  2020-12-24

8.  The influence of acute kidney disease on the clinical outcomes of patients who received cisplatin, carboplatin, and oxaliplatin.

Authors:  Alexandre Ricardo Da Silva Fernandes; Germana Alves de Brito; Aline Lourenço Baptista; Luis André Silvestre Andrade; Marina Harume Imanishe; Benedito Jorge Pereira
Journal:  Health Sci Rep       Date:  2022-01-12

9.  A developed model of cancer patients participation in intravenous chemotherapy safety.

Authors:  Zeng Na; Yan Qiaoyuan; Wang Binghan; Zhu Qin; Chen Yue; Peng Xin; Tan Cuilian; Yao Cheng
Journal:  Oncotarget       Date:  2017-09-18

10.  Patient-Oncologist Communication Regarding Oral Chemotherapy During Routine Office Visits.

Authors:  Bobbie K H Nguyen; Benjamin S Wu; Hanna K Sanoff; Jennifer Elston Lafata
Journal:  JCO Oncol Pract       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.